Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections
- 2.6k Downloads
Detection of α-synuclein lesions in peripheral tissues is a feature of human synucleinopathies of likely pathogenetic relevance and bearing important clinical implications. Experiments were carried out to elucidate the relationship between α-synuclein accumulation in the brain and in peripheral organs, and to identify potential pathways involved in long-distance protein transfer. Results of this in vivo study revealed a route-specific transmission of α-synuclein from the rat brain to the stomach. Following targeted midbrain overexpression of human α-synuclein, the exogenous protein was capable of reaching the gastric wall where it was accumulated into preganglionic vagal terminals. This brain-to-stomach connection likely involved intra- and inter-neuronal transfer of non-fibrillar α-synuclein that first reached the medulla oblongata, then gained access into cholinergic neurons of the dorsal motor nucleus of the vagus nerve and finally traveled via efferent fibers of these neurons contained within the vagus nerve. Data also showed a particular propensity of vagal motor neurons and efferents to accrue α-synuclein and deliver it to peripheral tissues; indeed, following its midbrain overexpression, human α-synuclein was detected within gastric nerve endings of visceromotor but not viscerosensory vagal projections. Thus, the dorsal motor nucleus of the vagus nerve represents a key relay center for central-to-peripheral α-synuclein transmission, and efferent vagal fibers may act as unique conduits for protein transfer. The presence of α-synuclein in peripheral tissues could reflect, at least in some synucleinopathy patients, an ongoing pathological process that originates within the brain and, from there, reaches distant organs innervated by motor vagal projections.
KeywordsAdeno-associated virus Enteric nervous system Parkinson’s disease Rat Synucleinopathies Vagus nerve
We thank Sarah A. Jewell for her comments on the manuscript, Omar El-Agnaf for kindly providing conformation-specific antibodies, Raffaella Rusconi for the design of in situ probes, Cherie N. Hudson, Bettina Winzen-Reichert, Franziska Hesse, Laura Jakobi for assistance with the experiments, and Ireen Koenig for assistance with microscopy. This work was supported by the Paul Foundation, the Centres of Excellence in Neurodegeneration Research (CoEN) and NIH Grant DK027627.
- 3.Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702. doi: 10.1007/s00401-010-0664-3 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Helwig M, Klinkenberg M, Rusconi R, Musgrove RE, Majbour NK, El-Agnaf OM, Ulusoy A, Di Monte DA (2016) Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice. Brain 139:856–870. doi: 10.1093/brain/awv376 CrossRefPubMedGoogle Scholar
- 16.Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL (2008) α-Synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson’s disease? Neuroscience 153:733–750. doi: 10.1016/j.neuroscience.2008.02.074 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Pouclet H, Lebouvier T, Coron E, Rouaud T, Flamant M, Toulgoat F, Roy M, Vavasseur F, Bruley des Varannes S, Neunlist M, Derkinderen P (2012) Analysis of colonic α-synuclein pathology in multiple system atrophy. Parkinsonism Relat Disord 18:893–895. doi: 10.1016/j.parkreldis.2012.04.020 CrossRefPubMedGoogle Scholar
- 20.Sánchez-Ferro Á, Rábano A, Catalán MJ, Rodríguez-Valcárcel FC, Fernández Díez S, Herreros-Rodríguez J, Garcia-Cobos E, Alvarez-Santullano MM, Lopez-Manzanares L, Mosqueira AJ, Vela Desojo L, Lopez-Lozano JJ, Lopez-Valdes E, Sanchez-Sanchez R, Molina-Arjona JA (2015) In vivo gastric detection of α-synuclein inclusions in Parkinson’s disease. Mov Disord 30:517–524. doi: 10.1002/mds.25988 CrossRefPubMedGoogle Scholar
- 26.Vaikath NN, Majbour NK, Paleologou KE, Ardah MT, van Dam E, van de Berg WD, Forrest SL, Parkkinen L, Gai WP, Hattori N, Takanashi M, Lee SJ, Mann DM, Imai Y, Halliday GM, Li JY, El-Agnaf OM (2015) Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology. Neurobiol Dis 79:81–99. doi: 10.1016/j.nbd.2015.04.009 CrossRefPubMedGoogle Scholar